Victory Capital Management
CRDF icon

Victory Capital Management’s Cardiff Oncology CRDF Stock Holding History

Victory Capital Management’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,633
Closed -$2K – 2682
2020
Q1 		$2K Buy
+1,633
New +$2.31K ﹤0.01% 3496
2019
Q4 		– Sell
-900
Closed -$1K – 2777
2019
Q3 		$1K Buy
+900
New +$1.75K ﹤0.01% 3691

Other funds holding CRDF

CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $80.9B AUM 26.08% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $1.12B AUM 390.6% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return

Victory Capital Management's CRDF Position: Q2 2020 in Review

Victory Capital Management sold out of Cardiff Oncology (CRDF) in Q2 2020, closing a stake of 1,633 shares — an estimated $2K sold.

Victory Capital Management first reported a position in CRDF in Q3 2019 and held it in 2 quarters. The position peaked at $2K in Q1 2020. 29 funds tracked by Wall St. Rank hold CRDF as of Q2 2020.

  • Victory Capital Management reported no remaining Cardiff Oncology position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 1,633 Cardiff Oncology shares in Q2 2020, an estimated $2K.
  • Victory Capital Management first reported a position in Cardiff Oncology in Q3 2019 and held it in 2 quarters.
  • Victory Capital Management's Cardiff Oncology position peaked at $2K in Q1 2020.
  • 29 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.